Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.
The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us...
Saved in:
Main Authors: | Timothy Caulfield, Jim Evans, Amy McGuire, Christopher McCabe, Tania Bubela, Robert Cook-Deegan, Jennifer Fishman, Stuart Hogarth, Fiona A Miller, Vardit Ravitsky, Barbara Biesecker, Pascal Borry, Mildred K Cho, June C Carroll, Holly Etchegary, Yann Joly, Kazuto Kato, Sandra Soo-Jin Lee, Karen Rothenberg, Pamela Sankar, Michael J Szego, Pilar Ossorio, Daryl Pullman, Francois Rousseau, Wendy J Ungar, Brenda Wilson |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/ad7dc7b64fbc41bd87b9096edfe82feb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neural and behavioral evidence for an intrinsic cost of self-control.
by: Wouter Kool, et al.
Published: (2013) -
Comparative efficacy of bepotastine besilate 1.5% ophthalmic solution versus olopatadine hydrochloride 0.2% ophthalmic solution evaluated by patient preference
by: McCabe CF, et al.
Published: (2012) -
Daily steps and healthcare costs in Japanese communities
by: Shohei Okamoto, et al.
Published: (2021) -
THE RESEARCH OF USING «THE COST RECOVERY» METHOD IN THE COST MANAGEMENT
by: Y. Vorontsova, et al.
Published: (2017) -
QUALITY COST REPORTING AS A DETERMINANT OF QUALITY COSTING MATURITY
by: Andrijana Rogošić
Published: (2021)